The landscape of dementia diagnosis has developed considerably with the appearance of subtle biomarkers, including amyloid PET scans, tau imaging, and blood-based checks which can detect Alzheimer's pathology years before indications arise. Although these technological developments represent extraordinary development in knowing neurodegenerative diseases, they may have not diminished ... https://henrikh208doy8.wiki-racconti.com/user